Hepatitis C virus infection and risk of stroke: A systematic review and meta-analysis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Huang, He ^a   Kang, Rongyan ^a   Zhao, Zhendong ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; RISK FACTOR; SYSTEMATIC REVIEW;

HEPACIVIRUS; HEPATITIS C; HUMANS; ODDS RATIO; PUBLICATION BIAS; RISK; STROKE;

EID: 84892998773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081305     Document Type: Article

References (32)

1. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567. doi:10.1016/S1473-3099(05)70216- 4. PubMed: 16122679. (Pubitemid 41196755)
2. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52. doi:10.1056/NEJM200107053450107. PubMed: 11439948. (Pubitemid 32634271)
3. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P (2009) Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 50: 1142-1154. doi:10.1016/j.jhep.2009.01.019. PubMed: 19395111.
4. White DL, Ratziu V, El-Serag HB (2008) Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 49: 831-844. doi:10.1016/j.jhep.2008.08.006. PubMed: 18814931.
5. Pereira AA, Jacobson IM (2009) New and experimental therapies for HCV. Nat. Rev Gastroenterol Hepatol 6: 403-411. doi:10.1038/nrgastro.2009.92.
6. Feigin VL (2007) Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol 6: 94-97. doi:10.1016/S1474- 4422(07)70007-8. PubMed: 17239789.
7. Strong K, Mathers C, Bonita R (2007) Preventing stroke: saving lives around the world. Lancet Neurol 6: 182-187. doi:10.1016/S1474-4422(07)70031-5. PubMed: 17239805. (Pubitemid 46097543)
8. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123. doi:10.1016/S0140-6736(10)60834-3. PubMed: 20561675.
9. Grau AJ, Urbanek C, Palm F (2010) Common infections and the risk of stroke. Nat Rev Neurology 6: 681-694. doi:10.1038/nrneurol.2010.163. PubMed: 21060340.
10. Forssen U, McAfee A, Enger C, Bennett D, Shantakumar S (2009) Risk of thromboembolic events (TEs) among patients infected with hepatitis C. Hepatology 50: 672A.
11. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH et al. (2010) Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 41: 2894-2900. doi:10.1161/STROKEAHA.110.598136. PubMed: 20966408.
12. Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC et al. (2013) Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan. Aliment Pharmacol Ther 38: 415-423. doi:10.1111/apt.12391. PubMed: 23802888.
13. Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A et al. (2013) Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 231: 22-26. doi:10.1016/j.atherosclerosis.2013.08.003. PubMed: 24125405.
14. Gutierrez J, Elkind MSV (2012) Chronic inflammatory diseases and stroke: Evidence for heterogeneous mechanisms. Ann Neurol 72: S6-S7. doi:10.1002/ana.23669.
15. Liao CC, Su TC, Sung FC, Chou WH, Chen TL (2012) Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLOS ONE 7: e31527. doi:10.1371/journal.pone.0031527. PubMed: 22363662.
16. Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E (2013) Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther 37: 647-652. doi:10.1111/apt.12234. PubMed: 23384408.
17. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535. doi:10.1136/bmj.b2535. PubMed: 19622551.
18. Wells GA SB, O'Connell D, Peterson J, Welch V (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
19. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. doi:10.1002/sim.1186. PubMed: 12111919. (Pubitemid 34746062)
20. Normand SL (1999) Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18: 321-359. doi:10.1002/(SICI)1097-0258(19990215)18:3. PubMed: 10070677.
21. Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20: 641-654. doi: 10.1002/sim.698. PubMed: 11223905. (Pubitemid 32166424)
22. Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY et al. (2013) Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern United States. AIDS Res Hum Retrovir 29: 1068-1074. doi:10.1089/aid.2012.0334. PubMed: 23565888.
23. Restivo L, Iuliano N, Nevola R, Amelia A, Fascione MC et al. (2013) Chronic HCV infection and extrahepatic diseases: Ischemic stroke and ischemic heart disease. Dig Liver Dis 45: S13. doi:10.1016/S1590-8658(13)60039-0.
24. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1-30. PubMed: 3678409.
25. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T (2003) Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 289: 1245-1246. doi:10.1001/jama.289.10.1245-a. PubMed: 12633185. (Pubitemid 37432904)
26. Ishizaka N, Ishizaka Y, Takahashi E, Toda E, Hashimoto H et al. (2002) Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 105: 1028-1030. doi:10.1161/hc0902.105718. PubMed: 11877348. (Pubitemid 34212607)
27. Ishizaka N, Ishizaka Y, Takahashi E, Tooda Ei, Hashimoto H et al. (2002) Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359: 133-135. doi: 10.1016/S0140-6736(02)07339- 7. PubMed: 11809259. (Pubitemid 34112545)
28. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22. doi: 10.1056/NEJM199901073400103. PubMed: 9878640. (Pubitemid 29024679)
29. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143. doi:10.1161/hc0902.104353. PubMed: 11877368. (Pubitemid 34212626)
30. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C et al. (2010) Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 47: 72-75. doi:10.1016/j.jcv.2009.10.005. PubMed: 19896417.
31. Patsopoulos NA, Evangelou E, Ioannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37: 1148-1157. doi:10.1093/ije/dyn065. PubMed: 18424475.
32. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC (2006) Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 163: 1042-1052. doi: 10.1093/aje/kwj141. PubMed: 16611666. (Pubitemid 43987597)